News
November 10, 2022
Yen Phan of CodLad won the Data Scientist Award for her contributions to the world of Data Science. Attracting entries from more than 170 companies…
We are thrilled to welcome MedDRA Face-to-Face training from 08-09 June 2023. MedDRA – the Medical Dictionary for Regulatory Activities – is a medical terminology…
November 11, 2021
CodLad is proud to announce that it is increasing its footprint by opening another office location in Japan. The new office located at the economic…
January 21, 2026
The U.S. Food and Drug Administration today announced its initial review of the effectiveness of the FDA ImportShield Program (FISP), which launched in August 2025…
January 21, 2026
Today, the U.S. Food and Drug Administration issued a Request for Information (RFI) regarding labeling and preventing cross-contact of gluten in packaged food. The FDA…
The U.S. Food and Drug Administration today published draft guidance designed to facilitate the use of Bayesian methodologies in clinical trials of drugs and biologics,…
January 11, 2026
The U.S. Food and Drug Administration today announced it is sharing information about the agency’s flexible approach to overseeing chemistry, manufacturing and control (CMC) requirements…
The U.S. Food and Drug Administration today released a congressionally mandated report under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA) evaluating the use…
December 19, 2025
The U.S. Food and Drug Administration today awarded national priority vouchers under the Commissioner’s National Priority Voucher (CNPV) pilot program to two investigational products for…
The U.S. Food and Drug Administration has issued a Request for Information (RFI) seeking input from venture capital firms on developing a new contracting approach…
December 15, 2025
The U.S. Food and Drug Administration today reminded industry of its legal responsibilities under the Federal Food, Drug, and Cosmetic Act regarding food recalls and…
December 15, 2025
The U.S. Food and Drug Administration (FDA) today removed a key limitation on the use of real-world evidence (RWE) used in drug and device applications…





